Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hepatitis C: early-phase trial registry
13 of 108 indexed Hepatitis C trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #119 of 28,707 conditions by registered trial count.
108 US clinical trials · 13 currently recruiting · #119 of 28,707 conditions by registered trial count
Hepatitis C: 108 US clinical trials tracked, 13 recruiting.
Hepatitis C is the subject of 108 registered US clinical trials on ClinicalTrials.gov, 13 of them currently open to new participants. 21 are in Phase 3-4 (later-stage) and 37 in Phase 1-2 (earlier-stage). The most active sponsor is Gilead Sciences, running 7 of these trials.
Enrollment posture brief
Registry condition hepatitis-c
OPEN 13 | RECR 12% | LATE 21 | EARLY 37 | RANK #119 | SPON 7
Volume-matched condition peers
Nearest open-share peer: HIV Infection (12% recruiting · 74 trials)
Hepatitis C lists 13 open slots (12% of 108 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hepatitis C on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hepatitis C is recruiting below its size-band peers.
13 of 108 indexed trials (12%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Hepatitis C trials is spread across many organizations.
Gilead Sciences accounts for 7 of 108 trials (6.5%). 67 distinct sponsors appear on at least one study for this condition label.
-
Typical Hepatitis C enrolment sits around 115 participants.
Median target enrolment is 115 among the 107 trials that report a genuine target (sentinel values excluded). 49 of those (45.8%) plan for fewer than 100 participants.
-
Hepatitis C research is mostly interventional.
86 interventional and 22 observational studies make up this index (79.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
108 total, page 3 of 3
Characterization of Clonal B Cell Populations in HCV Infection
Rockefeller University
NCT00435201
Study of the Immune Response to Hepatitis C Virus
Rockefeller University
NCT00237432
HCV-Smoking Cessation Study
Prisma Health-Upstate
NCT05466981
Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound
Northwell Health
NCT01208311
Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C
University of Pennsylvania
NCT03365635
Live Kidney Donors With Positive Anti-HCV Antibody, But Negative HCV PCR
University of Florida
NCT02669966
Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00100581
Herbal Treatment of Hepatitis C in Methadone Maintained Patients
National Center for Complementary and Integrative Health (NCCIH)
NCT00010816
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 14 |
| Phase 2 | 23 |
| Phase 3 | 11 |
| Phase 4 | 10 |
Top Sponsors
Named interventions
Most-linked intervention names on Hepatitis C records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hepatitis C trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hepatitis C page
108 registered trials, 13 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 13 Hepatitis C trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Gilead Sciences sponsors the most Hepatitis C trials on record, review their full trial history before evaluating a specific study. See Gilead Sciences's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hepatitis C condition card totals 108 registered trials; most-linked intervention Ribavirin; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.